GlassScriptPhysician profile
Huzaifa Haider
NPI 1497337430
$1,530.68
in general payments reported to CMS, 2019-2025
7 companies · $1,142 in 2025
The $1,142 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.04 · 2022: $26.36 · 2023: $214 · 2024: $129 · 2025: $1,142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,112 · Food and Beverage: $374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,111.61 |
| Food and Beverage | $373.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,111.61 | 2025 | |
| Aroa Biosurgery Incorporated | $136.62 | 2023 | |
| Orthofix Medical, INC. | $113.28 | 2024 | Physio-Stim |
| Depuy Synthes Sales INC. | $52.47 | 2022-2023 | Na |
| Kerecis Limited | $51.33 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Stryker Corporation | $46.33 | 2024-2025 | Augment Injectable, Viaflow, Flexband |
| Bioventus LLC | $19.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Huzaifa Haider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.